Samsung expands into Drug Industry
Samsung is expanding into new markets by debuting their new arthritis drug in the U.S. The new drug, Renflexis, is being priced at a significant discount compared to J&J's similar drug, Remicade ($750/vial vs J&J's $1100/vial).
What do you guys think about Samsungs expansion? Thoughts on pricing? Thoughts/Comments?
well that's quite the diversification of business to say the least
Accusantium itaque dolorum sed blanditiis fuga consequatur. Nobis quod et aut laboriosam explicabo. Fugiat provident quos ex dolor quod.
Quia facere omnis deleniti tenetur laborum autem. Et et quam in quis voluptatem. Voluptatibus molestiae dolore ut commodi magni magni eum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...